בודה כותנה התקנים אנליטית

Executive Industry Relevance

This cotton-based analytical device offers a low-cost, rapidly deployable solution for multi-analyte detection in resource-constrained settings. By leveraging the natural absorptive and hydrophobic properties of cellulose fibers, the platform enables contamination-resistant lateral flow assays for clinical urinalysis. Its simplicity and scalability support early-stage biomarker screening and assay development workflows in biopharma R&D.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables rapid screening of biomarker candidates in urine matrices using nitrite, protein, and urobilinogen readouts.
• Operational Value: Reduces assay development time through a fabricable, multi-test strip format requiring minimal instrumentation.

Screening & Assay Development

• Scientific Value: Provides a reproducible lateral flow format for optimizing colorimetric assays with defined limits of detection (nitrite: 0.147 mM, BSA: 3.7 µM, urobilinogen: 4.9 mg/L).
• Operational Value: Supports high-throughput strip fabrication (up to 36 devices per lamination sheet) for assay optimization and cross-lot consistency.

Translational & Preclinical Research

• Scientific Value: Facilitates pharmacokinetic and pharmacodynamic monitoring in preclinical models via non-invasive urine sampling.
• Operational Value: Enables longitudinal biomarker tracking with minimal sample volume and reduced cross-contamination risk.

Pipeline & Workflow Integration

The device fits within early discovery to preclinical workflows by providing a rapid, low-barrier method for urine-based analyte quantification, supporting go/no-go decisions in lead identification.

• Discovery Biology: Supports hypothesis testing of metabolic or renal pathway modulation through quantitative urinary biomarker measurement.
• Screening: Enables assay standardization via hydroponic cotton preparation and contact angle validation for batch-to-batch reproducibility.
• Analytics: Generates quantitative color intensity data convertible to concentration curves using ImageJ and regression modeling.
• Translational Research: Aligns with urinary biomarker continuity from discovery to preclinical validation for target engagement and safety monitoring.
• Enterprise Reuse: Represents a platform technology adaptable to multiple analyte panels beyond urinalysis through simple pad re-coating.

Operational & Enterprise Impact

• Scientific Value: Improves predictive confidence in biomarker assays by minimizing false signals from sample or reagent contamination.
• Operational Value: Delivers cost-effective, scalable assay production with assembly time under two hours post-training.
• Strategic Value: Reduces biological de-risking costs by enabling early validation of urinary biomarkers in discovery.
• Portfolio Impact: Supports risk-adjusted prioritization of targets with non-invasive, clinically translatable readouts.

Implementation Considerations

• Requires basic training in contact angle measurement to assess cotton hydrophobicity (target ~127°).
• Needs access to a laminator, precision cutter, and hole-punch for lamination film preparation.
• Demands standardized coating protocols for assay-specific indicator solutions (nitrite, BSA, urobilinogen).
• Requires image analysis capability (e.g., ImageJ) for grayscale conversion and intensity measurement.
• Performance depends on precise channel cutting depth (halfway through device) to ensure proper fluid wicking.

Biopharma FAQs